Does high urinary benzoic acid with very low hippuric acid reflect disrupted microbial aromatic metabolism or limited glycine conjugation?

The urinary benzoate-to-hippurate ratio is a clinical biomarker of host-microbiome co-metabolism, reflecting the interplay between gut microbial activity and hepatic detoxification capacity.

Glycine conjugation and metabolic bottlenecks

• Enzymatic kinetics: Benzoate detoxification occurs via a two-step mitochondrial pathway. Benzoate is first activated to benzoyl-CoA and then conjugated with glycine by the enzyme glycine N-acyltransferase (GLYAT) to form hippuric acid.
• Glycine depletion: GLYAT has a high affinity (low micromolar $K_m$) for benzoyl-CoA but a substantially lower affinity (millimolar $K_m$ range) for glycine. This makes glycine availability the rate-limiting bottleneck. When benzoate loads exceed conjugation capacity, local hepatic glycine pools deplete, GLYAT activity is limited, and free benzoic acid accumulates and is excreted in urine relative to hippurate.

Microbial dysbiosis and aromatic metabolism

• Symbiotic pathways: Gut microbes initiate this axis by metabolizing dietary polyphenols and aromatic amino acids (such as phenylalanine) into benzoic acid, which the host then absorbs and conjugates.
• Microbiome disruption: An abnormal urinary profile of high benzoate and very low hippurate is also associated with disrupted microbial aromatic compound metabolism. This metabolic signature is frequently observed in states of gut microbial dysbiosis, where a loss of microbial taxonomic diversity and gene richness impairs normal aromatic precursor degradation.

Bottom line

• An elevated urinary benzoic acid level paired with low hippuric acid is a validated biomarker of limited phase II glycine conjugation—typically caused by localized glycine depletion or impaired GLYAT capacity—while simultaneously reflecting disrupted gut microbial aromatic metabolism linked to dysbiosis.